Half of Fosun Pharma's Hong Kong IPO Will Fund Acquisitions

by Richard Daverman, PhD

October 17. 2012 -- Fosun Pharma’s $600 million Hong Kong IPO remains on track for completion this month, as the bankers have begun taking orders. Pricing will be on October 23, and the stock will begin trading on October 30. Half of the $600 million proceeds will be allocated to acquisitions, according to the company, which has a well-earned reputation as one of China pharma’s most active dealmakers. More details....

Stock Symbol: (SHA: 600196)